Novartis at ENA 2026
Nov 18–20, 2026 Barcelona, Spain ~1.5k attendees Website
Novartis brings 3 presentations to ENA 2026 in Barcelona. Its program centres on radioligand therapy and proximity-inducing drugs that go beyond current PROTACs. It also covers the practical side of running early radioligand therapy trials, from site selection to supply-chain challenges.
| Organization | ENA 2026 Attendance |
|---|---|
Novartis Basel, Switzerland | |
Global pharmaceutical company with oncology medicines including radioligand therapies and targeted agents. | Talk Wed Nov 18 5:15–5:35pm Session Fri Nov 20 9:30–10:45am Talk Fri Nov 20 9:30–9:35am |
Instantly find 20 buyers from Novartis
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by EORTC, the NCI or the AACR. Submit a correction